Michael Y. Aviram
#101,488
Most Influential Person Now
Michael Y. Aviram's AcademicInfluence.com Rankings
Michael Y. Avirambiology Degrees
Biology
#5095
World Rank
#7491
Historical Rank
Molecular Biology
#435
World Rank
#444
Historical Rank
Biochemistry
#575
World Rank
#665
Historical Rank
Download Badge
Chemistry Biology
Why Is Michael Y. Aviram Influential?
(Suggest an Edit or Addition)Michael Y. Aviram's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. (1998) (1187)
- Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. (2000) (865)
- Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. (1995) (662)
- Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. (1999) (641)
- Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. (2004) (636)
- Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. (2008) (624)
- Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. (1997) (567)
- Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. (2003) (515)
- Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. (1997) (481)
- Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. (2000) (466)
- Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. (1998) (464)
- Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. (2004) (443)
- Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. (2001) (438)
- Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer (2006) (418)
- Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial (2008) (404)
- Antioxidant activity, polyphenol content, and related compounds in different fruit juices and homogenates prepared from 29 different pomegranate accessions. (2007) (373)
- Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. (2000) (357)
- Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. (1997) (346)
- Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. (2006) (329)
- Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. (2001) (327)
- Polyphenols and Human Health: A Prospectus (2011) (312)
- Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation. (1998) (310)
- Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. (2000) (298)
- Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. (2002) (290)
- Flavonoids protect LDL from oxidation and attenuate atherosclerosis (2001) (287)
- Modified forms of low density lipoprotein and atherosclerosis. (1993) (283)
- Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. (2003) (282)
- Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteins. (2008) (261)
- Aldosterone Administration to Mice Stimulates Macrophage NADPH Oxidase and Increases Atherosclerosis Development: A Possible Role for Angiotensin-Converting Enzyme and the Receptors or Angiotensin II and Aldosterone (2004) (241)
- Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. (1983) (224)
- The Catalytic Histidine Dyad of High Density Lipoprotein-associated Serum Paraoxonase-1 (PON1) Is Essential for PON1-mediated Inhibition of Low Density Lipoprotein Oxidation and Stimulation of Macrophage Cholesterol Efflux* (2006) (224)
- Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. (1996) (217)
- Nutritional Antioxidants Mechanisms of Action, Analyses of Activities and Medical Applications (2001) (206)
- Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis (2011) (204)
- Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. (1997) (196)
- Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. (2005) (195)
- Wine Flavonoids Protect against LDL Oxidation and Atherosclerosis (2002) (192)
- Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. (1989) (186)
- Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel (2008) (176)
- Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid Lowering (2001) (174)
- Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL. (1997) (173)
- Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. (1994) (173)
- Mouse Macrophage Paraoxonase 2 Activity Is Increased Whereas Cellular Paraoxonase 3 Activity Is Decreased Under Oxidative Stress (2003) (168)
- Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis. (1998) (168)
- Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. (1991) (165)
- Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants. (1996) (160)
- Human Serum Paraoxonase 1 Decreases Macrophage Cholesterol Biosynthesis: Possible Role for Its Phospholipase-A2-Like Activity and Lysophosphatidylcholine Formation (2003) (160)
- Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy. (2003) (159)
- Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins. (1995) (155)
- Platelet interaction with high and low density lipoproteins. (1983) (154)
- The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. (1998) (153)
- Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. (2005) (151)
- The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9. (2002) (147)
- Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase. (2002) (146)
- The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. (1988) (146)
- Evidence of Intestinal Inflammation in Patients With Cystic Fibrosis (2010) (145)
- Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants. (2005) (145)
- Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. (2006) (144)
- Platelet activation by plasma lipoproteins. (1987) (143)
- Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities. (2008) (142)
- Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. (1994) (142)
- Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies. (1992) (142)
- Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences (2005) (141)
- White wine with red wine-like properties: increased extraction of grape skin polyphenols improves the antioxidant capacity of the derived white wine. (2001) (139)
- Oxidized Low Density Lipoprotein: Atherogenic and Proinflammatory Characteristics during Macrophage Foam Cell Formation. An Inhibitory Role for Nutritional Antioxidants and Serum Paraoxonase (1999) (139)
- Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. (2005) (137)
- Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes. (2002) (137)
- Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. (1988) (135)
- The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux Published, JLR Papers in Press, August 16, 2006.s⃞ (2006) (134)
- Platelet Factor 4 Enhances the Binding of Oxidized Low-density Lipoprotein to Vascular Wall Cells* (2003) (130)
- Angiotensin II Administration to Atherosclerotic Mice Increases Macrophage Uptake of Oxidized LDL: A Possible Role for Interleukin-6 (2001) (130)
- Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation. (1993) (130)
- Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. (2009) (129)
- Structural aspects of the inhibitory effect of glabridin on LDL oxidation. (1998) (128)
- Effect of Eplerenone, a Selective Aldosterone Blocker, on Blood Pressure, Serum and Macrophage Oxidative Stress, and Atherosclerosis in Apolipoprotein E–Deficient Mice (2003) (128)
- Primary ciliary dyskinesia caused by homozygous mutation in DNAL1, encoding dynein light chain 1. (2011) (128)
- Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy. (1998) (126)
- Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway. (2010) (126)
- Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis. (1978) (126)
- Clinical and Genetic Risk Factors for Cystic Fibrosis-related Liver Disease (1999) (126)
- Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype (2008) (125)
- Does paraoxonase play a role in susceptibility to cardiovascular disease? (1999) (123)
- Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages. (2005) (123)
- Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. (2005) (123)
- Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins (2001) (118)
- Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and AP-1 pathway activation. (2007) (116)
- Macrophage Enrichment with the Isoflavan Glabridin Inhibits NADPH Oxidase-induced Cell-mediated Oxidation of Low Density Lipoprotein (1999) (116)
- Pomegranate byproduct administration to apolipoprotein e-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoprotein. (2006) (116)
- Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. (1994) (112)
- A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice. (2006) (106)
- Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. (1992) (105)
- Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure. (2002) (104)
- LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants (1998) (102)
- Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages. (1996) (99)
- Paraoxonases role in the prevention of cardiovascular diseases (2009) (98)
- Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: inhibitory role for vitamin E. (2002) (96)
- Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis. (1999) (95)
- Paraoxonase 1 (PON1) reduces macrophage inflammatory responses. (2013) (94)
- Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface. (2002) (93)
- High density lipoprotein stimulates sterol translocation between intracellular and plasma membrane pools in human monocyte-derived macrophages. (1989) (92)
- Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice. (2002) (92)
- Effects of date ( Phoenix dactylifera L., Medjool or Hallawi Variety) consumption by healthy subjects on serum glucose and lipid levels and on serum oxidative status: a pilot study. (2009) (91)
- Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated. (1995) (89)
- DNAH11 Localization in the Proximal Region of Respiratory Cilia Defines Distinct Outer Dynein Arm Complexes. (2016) (88)
- A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations. (1997) (84)
- Haptoglobin Genotype Is a Regulator of Reverse Cholesterol Transport in Diabetes In Vitro and In Vivo (2006) (84)
- Oxidized low density lipoprotein leads to macrophage accumulation of unesterified cholesterol as a result of lysosomal trapping of the lipoprotein hydrolyzed cholesteryl ester. (1994) (84)
- The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release. (2011) (83)
- The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation. (1998) (83)
- Oxidized monocyte-derived macrophages in aortic atherosclerotic lesion from apolipoprotein E-deficient mice and from human carotid artery contain lipid peroxides and oxysterols. (2000) (80)
- Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion (2013) (80)
- Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. (1997) (79)
- Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2. (2005) (79)
- Pomegranate juice sugar fraction reduces macrophage oxidative state, whereas white grape juice sugar fraction increases it. (2006) (79)
- Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome (2020) (79)
- Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies. (1994) (78)
- Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice. (1997) (77)
- Decreased Macrophage Paraoxonase 2 Expression in Patients With Hypercholesterolemia Is the Result of Their Increased Cellular Cholesterol Content: Effect of Atorvastatin Therapy (2004) (76)
- Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins. (1999) (75)
- Choosing an oestrogen replacement therapy in young adult women with Turner syndrome* (2001) (75)
- Oxidative stress and macrophage foam cell formation during diabetes mellitus-induced atherogenesis: role of insulin therapy. (2012) (75)
- The effect of human plasma on platelet function in familial hypercholesterolemia. (1982) (75)
- Effect of a Mediterranean Meal on Postprandial Carotenoids, Paraoxonase Activity and C-Reactive Protein Levels (2006) (75)
- Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy. (1982) (74)
- Modified forms of low density lipoprotein affect platelet aggregation in vitro. (1989) (73)
- β-Carotene affects antioxidant status in non-insulin-dependent diabetes mellitus (1999) (73)
- Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation (2004) (73)
- Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: studies in vitro and in diabetic patients. (2010) (73)
- Enhanced in vitro platelet aggregation in hemodialysis patients. (1986) (72)
- Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux. (2008) (72)
- Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation. (1996) (71)
- Low density lipoprotein binding to human platelets: role of charge and of specific amino acids. (1981) (70)
- Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties. (2008) (70)
- Dietary Supplementation of a Natural Isomer Mixture of Beta-Carotene Inhibits Oxidation of LDL Derived from Patients with Diabetes mellitus (2000) (70)
- Characterization of the effect of plasma lipoproteins on platelet function in vitro. (1983) (70)
- Amphiphilic/Bipolar metallocorroles that catalyze the decomposition of reactive oxygen and nitrogen species, rescue lipoproteins from oxidative damage, and attenuate atherosclerosis in mice. (2008) (70)
- S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity. (2006) (69)
- Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages. (2004) (68)
- Paraoxonase 1 (PON1) is present in postprandial chylomicrons. (2005) (67)
- Effect of dietary supplementation of red or white wine on human blood chemistry, hematology and coagulation: favorable effect of red wine on plasma high-density lipoprotein. (1994) (67)
- Ox-LDL induces monocyte-to-macrophage differentiation in vivo: Possible role for the macrophage colony stimulating factor receptor (M-CSF-R). (2008) (66)
- Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients. (1994) (65)
- Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients (2001) (64)
- Pomegranate Protection against Cardiovascular Diseases (2012) (63)
- Increased Low‐Density Lipoprotein Levels After Splenectomy: A Role for the Spleen in Cholesterol Metabolism in Myeloproliferative Disorders (1986) (63)
- Markers for low-density lipoprotein oxidation. (2001) (63)
- Growth hormone and insulin-like growth factor-I increase macrophage uptake and degradation of low density lipoprotein. (1992) (63)
- Phagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell formation. Sequential morphological and biochemical events. (1991) (63)
- Introduction to the serial review on paraoxonases, oxidative stress, and cardiovascular diseases. (2004) (61)
- Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apo E knockout transgenic mice. (1994) (61)
- Evaluation of the World Health Organization criteria for chest radiographs for pneumonia diagnosis in children (2012) (60)
- Preferential Inhibition of LDL Oxidation by the all-trans Isomer of β-Carotene in Comparison with 9-cis β-Carotene (1993) (60)
- Platelet secretory products increase low density lipoprotein oxidation, enhance its uptake by macrophages, and reduce its fluidity. (1990) (59)
- Increased susceptibility to activation and increased uptake of low density lipoprotein by cholesterol-loaded macrophages. (1992) (58)
- HDL Apolipoprotein A-I Attenuates Oxidative Modification of Low Density Lipoprotein: Studies in Transgenic Mice (1995) (57)
- High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis. (1984) (57)
- Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose. (2005) (57)
- Accumulation of lipoprotein remnants in patients with chronic renal failure. (1983) (57)
- Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. (2009) (57)
- The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype (2008) (56)
- Book - The Paraoxonases: Their role in disease development and xenobiotic metabolism (2008) (56)
- Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1 Published, JLR Papers in Press, December 16, 2008. (2009) (56)
- Pomegranate phytosterol (β-sitosterol) and polyphenolic antioxidant (punicalagin) addition to statin, significantly protected against macrophage foam cells formation. (2013) (56)
- Red wine consumption and inhibition of LDL oxidation: what are the important components? (2002) (55)
- Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis. (1985) (55)
- Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients. (1997) (55)
- Consumption of pomegranate decreases serum oxidative stress and reduces disease activity in patients with active rheumatoid arthritis: a pilot study. (2011) (54)
- Apolipoprotein E and its role in aging and survival (2010) (53)
- Phenolic antioxidants and antiatherogenic effects of Marula (Sclerocarrya birrea Subsp. caffra) fruit juice in healthy humans. (2008) (52)
- LDL-Platelet Interaction Under Oxidative Stress Induces Macrophage Foam Cell Formation (1995) (52)
- Pomegranate juice polyphenols induce a phenotypic switch in macrophage polarization favoring a M2 anti-inflammatory state. (2015) (52)
- Low density lipoprotein modification by cholesterol oxidase induces enhanced uptake and cholesterol accumulation in cells. (1992) (51)
- Paraoxonase 1 (PON1) deficiency in mice is associated with reduced expression of macrophage SR-BI and consequently the loss of HDL cytoprotection against apoptosis. (2010) (50)
- Phospholipase A2-modified LDL is taken up at enhanced rate by macrophages. (1992) (50)
- Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection. (2020) (50)
- Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice (2017) (49)
- Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - a protective role for HDL phospholipids. (2010) (49)
- Increased plasma oxidizability and decreased erythrocyte and plasma antioxidative capacity in patients with NIDDM. (1999) (49)
- Retention of Oxidized LDL by Extracellular Matrix Proteoglycans Leads to Its Uptake by Macrophages: An Alternative Approach to Study Lipoproteins Cellular Uptake (2001) (49)
- Paraoxonases (PON1, PON2, PON3) analyses in vitro and in vivo in relation to cardiovascular diseases. (2008) (49)
- Anti-oxidant and anti-atherogenic properties of liposomal glutathione: studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice. (2007) (48)
- Effects of Pomegranate Extract Supplementation on Cardiovascular Risk Factors and Physical Function in Hemodialysis Patients. (2015) (48)
- Platelet lipoprotein interactions. (1988) (48)
- Oxidized low‐density lipoprotein (Ox‐LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS) (1997) (47)
- Platelet function and lipoprotein levels after plasma-exchange in patients with familial hypercholesterolaemia. (1983) (47)
- Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis. (2002) (47)
- The Middle Eastern and biblical origins of the Mediterranean diet (2011) (47)
- High Glucose Concentration Increases Macrophage Cholesterol Biosynthesis in Diabetes Through Activation of the Sterol Regulatory Element Binding Protein 1 (SREBP1): Inhibitory Effect of Insulin (2008) (46)
- High-density Lipoprotein Subfractions in Normolipidemic Patients with Coronary Atherosclerosis (1982) (46)
- Macrophage paraoxonase 1 (PON1) binding sites. (2008) (46)
- Preservation of Paraoxonase Activity by Wine Flavonoids (2002) (46)
- Directed evolution of serum paraoxonase PON3 by family shuffling and ancestor/consensus mutagenesis, and its biochemical characterization. (2009) (45)
- Silicon dioxide nanoparticles increase macrophage atherogenicity: Stimulation of cellular cytotoxicity, oxidative stress, and triglycerides accumulation (2016) (45)
- ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I. (2010) (43)
- Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta. (2009) (43)
- Paraoxonase 1 (PON1) inhibits monocyte-to-macrophage differentiation. (2011) (42)
- Valsartan Therapy Has Additive Anti-oxidative Effect to That of Fluvastatin Therapy Against Low-Density Lipoprotein Oxidation: Studies in Hypercholesterolemic and Hypertensive Patients (2002) (42)
- Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production. (1985) (41)
- Reproducibility of nasal potential difference measurements in cystic fibrosis. (2007) (41)
- Fatal multiple organ failure following massive hornet stings. (1995) (41)
- Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity. (2008) (41)
- Postnatal management of resolving fetal lung lesions. (2002) (40)
- Cell-induced copper ion-mediated low density lipoprotein oxidation increases during in vivo monocyte-to-macrophage differentiation. (2004) (40)
- Pomegranate extract (POMx) decreases the atherogenicity of serum and of human monocyte-derived macrophages (HMDM) in simvastatin-treated hypercholesterolemic patients: a double-blinded, placebo-controlled, randomized, prospective pilot study. (2014) (40)
- Reduction of plasma cholesterol by lovastatin normalizes erythrocyte membrane fluidity in patients with severe hypercholesterolaemia. (1992) (40)
- Abnormal plasma lipoprotein composition in hypercholesterolaemic patients induces platelet activation (1984) (39)
- Antioxidant and antiatherogenic properties of phenolic acid and flavonol fractions of fruits of 'Amari' and 'Hallawi' date (Phoenix dactylifera L.) varieties. (2015) (39)
- Pomegranate juice (PJ) consumption antioxidative properties on mouse macrophages, but not PJ beneficial effects on macrophage cholesterol and triglyceride metabolism, are mediated via PJ-induced stimulation of macrophage PON2. (2010) (39)
- Effect of Lipoproteins and Platelets on Macrophage Cholesterol Metabolism (1991) (39)
- Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284. (2011) (39)
- Flavonoids-rich nutrients with potent antioxidant activity prevent atherosclerosis development: the licorice example (2004) (39)
- Intralipid Infusion Abolishes Ability of Human Serum to Cholesterol‐load Cultured Macrophages (1989) (38)
- The effect of blood constituents on platelet function: role of blood cells and plasma lipoproteins. (1983) (38)
- Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for D-glucose. (2007) (38)
- Microsomal cytochromes P450 catalyze the oxidation of low density lipoprotein. (1999) (37)
- A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity. (2006) (37)
- Consumption of polyphenolic-rich beverages (mostly pomegranate and black currant juices) by healthy subjects for a short term increased serum antioxidant status, and the serum's ability to attenuate macrophage cholesterol accumulation. (2010) (37)
- Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice. (2000) (37)
- Specific Amino Acids Affect Cardiovascular Diseases and Atherogenesis via Protection against Macrophage Foam Cell Formation: Review Article (2018) (37)
- Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathway. (2013) (36)
- Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner. (2007) (36)
- Dietary soya lecithin decreases plasma triglyceride levels and inhibits collagen- and ADP-induced platelet aggregation. (1986) (36)
- Paraoxonase 2 (PON2) decreases high glucose-induced macrophage triglycerides (TG) accumulation, via inhibition of NADPH-oxidase and DGAT1 activity: studies in PON2-deficient mice. (2010) (36)
- Macrophages from alpha 7 nicotinic acetylcholine receptor knockout mice demonstrate increased cholesterol accumulation and decreased cellular paraoxonase expression: a possible link between the nervous system and atherosclerosis development. (2009) (36)
- Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice (2019) (36)
- Fosinopril reduces ADP-induced platelet aggregation in hypertensive patients. (1996) (35)
- Preservation of paraoxonase activity by wine flavonoids: possible role in protection of LDL from lipid peroxidation. (2002) (35)
- Enhanced lipid oxidation by oxidatively modified myoglobin: role of protein-bound heme. (2000) (35)
- Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis. (2016) (34)
- Protecting the beneficial functionality of lipoproteins by 1-Fe, a corrole-based catalytic antioxidant (2011) (34)
- Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients. (2000) (34)
- Activated platelets secrete a protein-like factor that stimulates oxidized-LDL receptor activity in macrophages. (1991) (33)
- High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx. (2010) (33)
- Prenatal Diagnosis of Congenital Lobar Emphysema (2009) (33)
- Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein. (2000) (33)
- Excessive dietary tryptophan enhances plasma lipid peroxidation in rats. (1991) (33)
- Tissue Angiotensin-Converting-Enzyme (ACE) Deficiency Leads to a Reduction in Oxidative Stress and in Atherosclerosis: Studies in ACE-Knockout Mice Type 2 (2003) (33)
- Normolipidemic xanthelasma palpebrarum: lipid composition, cholesterol metabolism in monocyte-derived macrophages, and plasma lipid peroxidation. (1996) (32)
- Consumption of eggs with meals increases the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. (1996) (31)
- Validation and Reduction of the Oxidative Stress Following Laparoscopic Operations: A Prospective Randomized Controlled Study (2007) (31)
- Atherogenicity of amino acids in the lipid-laden macrophage model system in vitro and in atherosclerotic mice: a key role for triglyceride metabolism. (2017) (31)
- Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age. (2019) (31)
- Increased macrophage cholesterol biosynthesis and decreased cellular paraoxonase 2 (PON2) expression in Delta6-desaturase knockout (6-DS KO) mice: beneficial effects of arachidonic acid. (2010) (31)
- Characterization of oxidative stress in blood from diabetic vs. hypercholesterolaemic patients, using a novel synthesized marker (2008) (31)
- Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis (2013) (30)
- Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia. (2017) (30)
- Platelet secretory products enhance LDL receptor activity and inhibit scavenger receptor activity in human monocyte derived macrophages. (1989) (30)
- Angiotensin II reduces macrophage cholesterol efflux: a role for the AT-1 receptor but not for the ABC1 transporter. (2002) (30)
- Decreased sensitivity to insulin‐like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes (1997) (30)
- Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects. (1984) (30)
- Pomegranate for Your Cardiovascular Health (2013) (30)
- Effect of dietary supplementation of beta-carotene on human monocyte-macrophage-mediated oxidation of low density lipoprotein. (1996) (30)
- Postprandial serum triacylglycerols and oxidative stress in mice after consumption of fish oil, soy oil or olive oil: possible role for paraoxonase-1 triacylglycerol lipase-like activity. (2006) (29)
- Anti-atherogenic properties of date vs. pomegranate polyphenols: the benefits of the combination. (2015) (29)
- Macrophage released proteoglycans are involved in cell-mediated aggregation of LDL. (1999) (29)
- Increased platelet aggregation during alimentary hyperlipemia in normal and hypertriglyceridemic subjects. (1986) (29)
- Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein. (1992) (29)
- Polyphenols and Flavonoids Protect LDL Against Atherogenic Modifications (2001) (28)
- THE LICORICE ROOT DERIVED ISOFLAVAN GLABRIDIN INHIBITS THE ACTIVITIES OF HUMAN CYTOCHROME P 450 S 3 A 4 , 2 B 6 , AND 2 C 9 (2002) (28)
- Paraoxonase 1 protects macrophages from atherogenicity of a specific triglyceride isolated from human carotid lesion. (2011) (28)
- The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: Implications for newborn screening. (2016) (28)
- Impact of heme oxygenase‐1 on cholesterol synthesis, cholesterol efflux and oxysterol formation in cultured astroglia (2009) (28)
- Red wine consumption inhibits LDL oxidation and aggregation in humans and in atherosclerotic mice (1997) (28)
- Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies. (2009) (28)
- Acetylcholine esterase protects LDL against oxidation. (2004) (28)
- Familial homozygous hypercholesterolemia: Clinical and cardiovascular features in 18 patients (1989) (27)
- Platelet-Modified Low Density Lipoprotein Induces Macrophage Cholesterol Accumulation and Platelet Activation (1989) (27)
- Intralipid infusion into humans reduces in vitro platelet aggregation and alters platelet lipid composition. (1989) (26)
- Familial concordance of phenotype and microbial variation among siblings with CF (2004) (26)
- Reduced uptake of cholesterol esterase-modified low density lipoprotein by macrophages. (1991) (26)
- Oxidized LDL binding to a macrophage-secreted extracellular matrix. (1997) (26)
- araoxonase 1 ( PON 1 ) expression in hepatocytes is upregulated by pomegranate olyphenols : A role for PPAR-pathway (2009) (25)
- Systemic inflammatory mediators and cystic fibrosis genotype (2004) (25)
- Angiotensin II Enhances Lipid Peroxidation of Low-Density Lipoprotein (1993) (25)
- Chylomicrons from patients with type V hyperlipoproteinemia inhibit platelet function. (1985) (25)
- The contribution of the macrophage receptor for oxidized LDL to its cellular uptake. (1991) (25)
- Platelet-modified low-density lipoproteins: studies in normal subjects and in patients with homozygous familial hypercholesterolemia. (1987) (24)
- Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDL. (1992) (23)
- Pomegranate Juice Protects Macrophages from Triglyceride Accumulation: Inhibitory Effect on DGAT1 Activity and on Triglyceride Biosynthesis (2011) (23)
- Cystic Fibrosis Transmembrane Conductance Regulator Ion Channel Function Testing in Recurrent Acute Pancreatitis (2008) (23)
- Low-density lipoprotein and scavenger receptor activities are modulated by secretory products derived from cells of the arterial wall. (1989) (22)
- Paraoxonase-1 and clopidogrel efficacy (2011) (22)
- Malondialdehyde affects the physico-chemical and biological characteristics of oxidized low density lipoprotein. (1990) (22)
- Phospholipase D-modified low density lipoprotein is taken up by macrophages at increased rate. A possible role for phosphatidic acid. (1993) (22)
- Date (Phoenix dactylifera L.) fruit soluble phenolics composition and anti-atherogenic properties in nine Israeli varieties. (2013) (22)
- LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients. (2007) (22)
- Pulmonary involvement in Niemann-Pick C type 1 (2018) (22)
- Anti-atherogenicity of nutritional antioxidants. (2001) (22)
- Variables that influence cellular uptake and cytotoxic/cytoprotective effects of macrocyclic iron complexes. (2012) (22)
- Paraoxonase 1 attenuates human plaque atherogenicity: relevance to the enzyme lactonase activity. (2010) (22)
- Effect of low altitude at the Dead Sea on exercise capacity and cardiopulmonary response to exercise in cystic fibrosis patients with moderate to severe lung disease (2006) (22)
- Selective release from platelet granules induced by plasma lipoproteins. (1984) (22)
- Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism (2008) (21)
- Lysophosphatidylcholine (LPC) attenuates macrophage-mediated oxidation of LDL. (2006) (21)
- Oxidative modification of low density lipoprotein and its relation to atherosclerosis. (1995) (21)
- Macrophage paraoxonase 2 (PON2) expression is upregulated by unesterified cholesterol through activation of the phosphatidylinositol 3-kinase (PI3K) pathway (2007) (21)
- Monitoring theophylline therapy using citric acid-stimulated saliva in infants and children with asthma. (1987) (21)
- Oxidative stress and nephrolithiasis: a comparative pilot study evaluating the effect of pomegranate extract on stone risk factors and elevated oxidative stress levels of recurrent stone formers and controls (2014) (21)
- Pomegranate juice consumption reduces oxidative stress and low density lipoprotein atherogenic modifications: studies in the atherosclerotic apolipoprotein E deficient mice and in humans (2000) (21)
- Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol. (1983) (20)
- Proteins derived from platelet alpha granules modulate the uptake of oxidized low density lipoprotein by macrophages. (1992) (20)
- Human carotid plaque phosphatidylcholine specifically interacts with paraoxonase 1, increases its activity, and enhances its uptake by macrophage at the expense of its binding to HDL. (2014) (20)
- Platelet secreted lipoprotein-like particle is taken up by the macrophage scavenger receptor and enhances cellular cholesterol accumulation. (1991) (19)
- Oxidative Stress in Cardiovascular Disease: Role of Oxidized Lipoproteins in Macrophage Foam Cell Formation and Atherosclerosis (2003) (19)
- Serotonin increases macrophage uptake of oxidized low density lipoprotein. (1992) (19)
- Increased plasma triglycerides, cholesterol and apolipoprotein E during prolonged fasting in normal subjects. (1985) (19)
- The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate. (1980) (18)
- Serum Lipoprotein Profile in Children With Celiac Disease (1990) (18)
- Platelet function in a case with abetalipoproteinemia. (1985) (18)
- Atherosclerosis: cell biology and lipoproteins--inflammation and oxidative stress in atherogenesis: protective role for paraoxonases. (2011) (18)
- Atherosclerosis and the protective role played by different proteins in apolipoprotein E-deficient mice. (2007) (18)
- Paraoxonase Activity and Expression Is Modulated by Therapeutics in Experimental Rat Nonalcoholic Fatty Liver Disease (2012) (18)
- Pomegranate Juice Polyphenols Induce Macrophage Death via Apoptosis as Opposed to Necrosis Induced by Free Radical Generation: A Central Role for Oxidative Stress (2016) (17)
- Triglyceride accumulation in macrophages upregulates paraoxonase 2 (PON2) expression via ROS-mediated JNK/c-Jun signaling pathway activation. (2012) (17)
- Preferential inhibition of LDL oxidation by the all-trans isomer of beta-carotene in comparison with 9-cis beta-carotene. (1993) (17)
- VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies. (2012) (17)
- Plasma Lipoproteins and Coronary Artery Disease. (1993) (17)
- Baseline Cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression. (2020) (17)
- Comprar The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism | Mackness, Bharti | 9781402065606 | Springer (2008) (16)
- CFAP45 deficiency causes situs abnormalities and asthenospermia by disrupting an axonemal adenine nucleotide homeostasis module (2020) (16)
- Enhanced low-density lipoprotein degradation and cholesterol synthesis in monocyte-derived macrophages of patients with adult xanthogranulomatosis. (1993) (16)
- Urokinase-Type Plasminogen Activator Downregulates Paraoxonase 1 Expression in Hepatocytes by Stimulating Peroxisome Proliferator–Activated Receptor-&ggr; Nuclear Export (2012) (16)
- Exogenous N-linoleoyl tyrosine marker as a tool for the characterization of cellular oxidative stress in macrophages (2006) (16)
- Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm progression. (2016) (16)
- Omapatrilat Decreased Macrophage Oxidative Status and Atherosclerosis Progression in Atherosclerotic Apolipoprotein E-Deficient Mice (2004) (15)
- Reduced susceptibility of low density lipoprotein to lipid peroxidation after cholestyramine treatment in heterozygous familial hypercholesterolemic children. (2001) (15)
- Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity. (2011) (15)
- Increased susceptibility to undergo lipid peroxidation of chylomicrons and low-density lipoprotein in celiac disease. (1993) (15)
- Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid. (2012) (15)
- Platelets and the arterial wall lesion (1992) (15)
- Consumption of a novel dietary formula of plant sterol esters of canola oil fatty acids, in a canola oil matrix containing 1,3-diacylglycerol, reduces oxidative stress in atherosclerotic apolipoprotein E-deficient mice. (2007) (15)
- Increased Levels of Human Carotid Lesion Linoleic Acid Hydroperoxide in Symptomatic and Asymptomatic Patients Is Inversely Correlated with Serum HDL and Paraoxonase 1 Activity (2012) (15)
- Supplementation with linoleic acid‐rich soybean oil stimulates macrophage foam cell formation via increased oxidative stress and diacylglycerol acyltransferase1‐mediated triglyceride biosynthesis (2017) (14)
- Reply to P Caldú et al (1996) (14)
- Glucose Inactivates Paraoxonase 1 (PON1) and Displaces it from High Density Lipoprotein (HDL) to a Free PON1 Form (2008) (14)
- Changes in lipoproteins and subfractions following oophorectomy and oestrogen replacement in peri-menopausal women. (1983) (14)
- Increased concentration of high density lipoprotein in plasma and decreased platelet aggregation in primary biliary cirrhosis. (1984) (14)
- Dual Effect of Lovastatin and Simvastatin on LDL-Macrophage Interaction (1991) (14)
- Leucine supplementation attenuates macrophage foam‐cell formation: Studies in humans, mice, and cultured macrophages (2018) (14)
- Macrophage cholesterol removal by triglyceride-phospholipid emulsions. (1988) (14)
- Prenatal Diagnosis of a Rare Sonographic Appearance of Duodenal Atresia (2012) (13)
- Paraoxsonase2 (PON2) and oxidative stress involvement in pomegranate juice protection against cigarette smoke-induced macrophage cholesterol accumulation. (2016) (13)
- Intralipid infusion in patients with familial hypercholesterolemia. Effect of serum and plasma lipoproteins on platelet aggregation and on macrophage cholesterol metabolism. (1990) (13)
- Plasma cholesterol concentration and extra lipid band in monoclonal gammopathies. (1984) (13)
- POMEGRANATE AND CARDIOVASCULAR DISEASES: POMEGRANATE JUICE POLYPHENOLIC ANTIOXIDANTS PROTECT AGAINST OXIDATIVE STRESS AND ATHEROSCLEROSIS DEVELOPMENT (2007) (13)
- Endogenous or exogenous antioxidants vs. pro-oxidants in macrophage atherogenicity. (2016) (12)
- Nitro-Oleic Acid Reduces J774A.1 Macrophage Oxidative Status and Triglyceride Mass: Involvement of Paraoxonase2 and Triglyceride Metabolizing Enzymes (2016) (12)
- Metformin inhibits macrophage cholesterol biosynthesis rate: possible role for metformin-induced oxidative stress. (2013) (12)
- High glucose upregulates C-reactive protein synthesis in macrophages. (2010) (12)
- Paraoxonase 1 interactions with atherosclerotic lesions and arterial macrophages protect against foam cell formation and atherosclerosis development (2010) (12)
- Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism. (2018) (12)
- Serum CA 19–9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests (2003) (11)
- Secretory products from human monocyte-derived macrophages enhance platelet aggregation. (1991) (11)
- Trampoline use as physiotherapy for cystic fibrosis patients (2005) (11)
- Oxidative stress increases the expression of the angiotensin-II receptor type 1 in mouse peritoneal macrophages (2002) (11)
- Cholesterol, Linoleic Acid or/and Tyrosine Yield Different Spectra of Products when Oxidized Alone or in a Mixture: Studies in Various Oxidative Systems (2003) (11)
- Aqueous or lipid components of atherosclerotic lesion increase macrophage oxidation and lipid accumulation. (2016) (11)
- PLATELET FUNCTION IN BEHÇET'S DISEASE (1984) (11)
- Oxidative stress increases the expression of the angiotensin-II receptor type 1 in mouse peritoneal macrophages. (2001) (10)
- The effect of the COVID-19 lockdown on children with asthma-related symptoms: A tertiary care center experience (2021) (10)
- [Macrophages and atherosclerosis]. (1989) (10)
- Hyperlipidaemia and cardiovascular disease: inflammation and oxidative stress in diabetic patients. (2009) (10)
- Reduced plasma high-density lipoprotein and increased platelet activity in arterial versus venous blood. (1987) (10)
- Postprandial plasma lipoproteins in normal and hypertriglyceridaemic subjects and their in vitro effect on platelet activity: differences between saturated and polyunsaturated fats. (1986) (10)
- Lipoprotein Platelet Interaction: The Effect On Platelet Cholesterol Content And Platelet Function (1981) (10)
- Differential effect of platelet inhibitors in normal and in hypercholesterolaemic subjects. (1985) (9)
- Residual small airways lesions after kerosene pneumonitis in early childhood (1984) (9)
- Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma. (1990) (9)
- Prenatal exposure to H2 blockers and to proton pump inhibitors and asthma development in offspring (2016) (9)
- Phospholipase A2 and phospholipase D are involved in macrophage NADPH oxidase-mediated oxidation of low density lipoprotein. (1996) (9)
- The effects of time interval after venipuncture and of anticoagulation on platelet adhesion and aggregation. (1996) (9)
- Serum Paraoxonase Activity and the Extent of Lipid Peroxidation Are not Affected by Increased Levels of Human Apolipoprotein A-I: Studies in Transgenic Mice (2002) (9)
- Low-density lipoprotein derived from atherosclerotic patients enhances macrophage cholesterol accumulation and in vitro platelet aggregation. (1989) (9)
- Increased platelet aggregation following splenectomy in patients with myeloproliferative disease. (1985) (9)
- Introduction to Paraoxonases (2012) (9)
- Arterial blood derived low density lipoprotein increases platelet aggregation and macrophage cholesterol content in comparison to lipoprotein derived from veinous blood. (1989) (9)
- Increased Plasma Oxidizability in Subjects with Severe Obesity (1996) (8)
- Macrophage endoplasmic reticulum (ER) proteins and reducing elements stabilize paraoxonase 2 (PON2). (2010) (8)
- Modification of LDL by platelet secretory products induces enhanced uptake and cholesterol accumulation in macrophages. (1989) (8)
- The Effects of Pomegranate Extract (POMx), Simvastatin, or Metformin Therapies in Hypercholesterolemic or in Diabetic Patients on Daily Rhythms of Serum Lipids and of Oxidative Stress: A Pilot Study (2014) (8)
- Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis. (2021) (8)
- Primary ciliary dyskinesia in Israel: Prevalence, clinical features, current diagnosis and management practices. (2016) (8)
- High-density lipoprotein composition in chronic hemodialysis. (1979) (8)
- Branched-chain amino acids and atherosclerosis: friends or foes? (2018) (8)
- Paraoxonase 1 (PON1) and pomegranate influence circadian gene expression and period length (2016) (7)
- In vitro effects of exogenous carbon monoxide on oxidative stress and lipid metabolism in macrophages (2016) (7)
- Selective oxidative stress and cholesterol metabolism in lipid-metabolizing cell classes: Distinct regulatory roles for pro-oxidants and antioxidants. (2015) (7)
- A Sex-dependent Effect of Aspirin on Platelet Membrane Fluidity. (1992) (7)
- b-Carotene affects antioxidant status in non-insulin-dependent diabetes mellitus (1999) (7)
- Prednisone and Its Active Metabolite Prednisolone Attenuate Lipid Accumulation in Macrophages (2019) (7)
- Oral and Poster Presentations (2003) (7)
- Exogenous (Pomegranate Juice) or Endogenous (Paraoxonase1) Antioxidants Decrease Triacylglycerol Accumulation in Mouse Cardiovascular Disease-Related Tissues. (2018) (7)
- Insulin increases macrophage triglyceride accumulation under diabetic conditions through the down regulation of hormone sensitive lipase and adipose triglyceride lipase. (2011) (7)
- Iron induces lipid peroxidation in cultured macrophages and affects their secretory properties (1994) (7)
- Corrigendum to “Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation” [Clin. Nutr. 23 (2004) 423–433] (2008) (7)
- The effect of oestrogen implants on high density lipoproteins and its subfractions in women in their pre-mature menopause. (1982) (7)
- High intrinsic aerobic capacity and pomegranate juice are protective against macrophage atherogenecity: studies in high- vs. low-capacity runner (HCR vs. LCR) rats. (2015) (7)
- It is not just lipids: proatherogenic vs. antiatherogenic roles for amino acids in macrophage foam cell formation. (2017) (7)
- The effect of platelets on macrophage lipoprotein metabolism. (1988) (7)
- Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis (2022) (7)
- Allosteric inhibitors of HMG-CoA reductase, the key enzyme involved in cholesterol biosynthesis. (2013) (7)
- Pomegranate Phenolic Antioxidant Activities Protect Against Cardiovascular Diseases (2008) (6)
- Lipid Profile and Serum Characteristics of the Blind Subterranean Mole Rat, Spalax (2009) (6)
- The effect of probucol on HDL-mediated sterol translocation and efflux from cells. (1992) (6)
- Red wine administration to apolipoprotein E-deficient mice reduces their macrophage-derived extracellular matrix atherogenic properties. (2004) (6)
- Atherosclerosis: cell biology and lipoproteins--oxidative stress and paraoxonases regulate atherogenesis. (2010) (6)
- Macrophage activation with phorbol myristate acetate is associated with cellular lipid peroxidation. (1996) (6)
- Wine flavonoids, LDL cholesterol oxidation and atherosclerosis (2002) (6)
- Paraoxonase 1 deficiency in mice is associated with reduced steroid biosynthesis: effects on HDL binding, cholesteryl ester accumulation and scavenger receptor type BI expression. (2010) (6)
- Human carotid atherosclerotic plaque protein(s) change HDL protein(s) composition and impair HDL anti-oxidant activity. (2016) (6)
- Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening (2017) (6)
- High density lipoprotein in octogenarians. (1983) (6)
- Lipid peroxidation and atherosclerosis: the importance of selected patient group analysis. (2003) (6)
- Lipid-protein particles secreted from activated platelets reduce macrophage uptake of low density lipoprotein. (1991) (6)
- Slfn2 mutation‐induced loss of T‐cell quiescence leads to elevated de novo sterol synthesis (2017) (5)
- Neutral lipid storage disease with ichthyosis: Serum apolipoprotein levels and cholesterol metabolism in monocyte-derived macrophages (1991) (5)
- Antiatherogenicity of antioxidants against LDL oxidation. (1999) (5)
- Lipoprotein interactions with chromatic membranes as a novel marker for oxidative stress-related diseases. (2009) (5)
- Restoration of CFTR function by gentamincin in cystic fibrosis patients carrying stop mutations: a double blind placebo controlled trial (2003) (5)
- Plasma lipoprotein pattern and decreased platelet function in type V hyperlipoproteinemia. (1985) (5)
- Platelet secretory substances enhance in vitro plasma coagulation. (1990) (5)
- High‐density lipoprotein‐associated paraoxonase 1: a possible prognostic biomarker for heart failure? (2017) (5)
- The effect of the COVID‐19 lockdown on children with asthma‐related symptoms: A tertiary care center experience (2021) (5)
- Dietary tryptophan enhances platelet aggregation in rats. (1990) (5)
- Comparison of septic and nonseptic pulmonary embolism in children (2021) (4)
- Chylomicronaemia in multiple myeloma. (2009) (4)
- Plasma lipoprotein and platelet function after heparin injection: studies in normal fasted and postprandial and in type V hyperlipoproteinemic subjects. (1986) (4)
- Collecting clinical data in primary ciliary dyskinesia- challenges and opportunities (2016) (4)
- Chromatic polymer assays for the analysis of lipid and lipoprotein peroxidation (2015) (4)
- Colorimetric Polymer Assay for the Diagnosis of Plasma Lipids Atherogenic Quality in Hypercholesterolemic Patients (2015) (4)
- Intraperitoneal injection of platelet secretory products into mice increases macrophage uptake of oxidized low density lipoprotein. (1993) (4)
- Human carotid atherosclerotic lesion protein components decrease cholesterol biosynthesis rate in macrophages through 3-hydroxy-3-methylglutaryl-CoA reductase regulation. (2015) (4)
- Plasma Lipoproteins and Platelet Aggregation During Alimentary Lipemia (1986) (4)
- Antioxidants as Targeted Therapy: A Special Protective Role for Pomegranate and Paraoxonases (PONs) (2011) (4)
- An effective method for plasma lipoprotein separation: studies of various animal species. (1989) (3)
- Protective Effect of Low Concentrations of Oxidized Low-Density Lipoprotein on Endothelial Cell Integrity (1995) (3)
- Atorvastatin Therapy Increases Monocyte / Macrophage Paraoxonase 2 Expression and Reduces Oxidative Stress in Hyprecholesterolemic Patients (2004) (3)
- Soybean Oil Modulates the Gut Microbiota Associated with Atherogenic Biomarkers (2020) (3)
- Reply to Chow (2006) (3)
- Adult xanthogranulomatosis associated with abnormal plasma apolipoprotein levels (1990) (3)
- Decreased very low density lipoprotein fluidity in familial hypercholesterolemia. (1991) (3)
- Platelet-modified lipoprotein induced by thrombin: effect of whole blood and plasma. (1988) (3)
- HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies. (2014) (3)
- Pro-atherogenic and pro-oxidant crosstalk between adipocytes and macrophages (2019) (3)
- Impaired Cholesterol Synthesis Rate in Fibroblasts and Reduced Cellular Uptake of LDLs Derived from Peroxisome‐deficient Patients Cause Cellular Cholesterol Deficiency in Peroxisome‐deficient Fibroblasts a (1996) (3)
- Lipoprotein secretion by human monocyte derived macrophages. (1988) (3)
- High density lipoprotein and arteriosclerosis. Different patterns in primary hypothyroidism and type IIa hyperlipoproteinemia. (1981) (3)
- [Plasma lipids in vegetarians in Israel]. (1982) (3)
- The acute effects of high cholesterol and saturated fat diet on plasma lipoproteins and on platelet aggregation in normolipidemic subjects (1986) (3)
- Low density lipoprotein-cholesteryl ester-derived linoleic acid is mainly incorporated into the phospholipid component of the macrophages. (1995) (3)
- , Mira Activities : Selective Action of Human Paraoxonase Allozymes Q and R Sulfhydryl Group and Is Different From That Required for Its Arylesterase / Paraoxonase Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free (1998) (3)
- Licorice Root Flavonoid Antioxidants Reduce LDL Oxidation and Attenuate Cardiovascular Diseases (2004) (3)
- Antiatherogenic effect of lycopene and β-carotene: inhibition of LDL oxidation and suppression of cellular cholesterol synthesis. (1999) (3)
- Effect of plasma lipoproteins on cholesterol accumulation in macrophages: comparison of lipoproteins from normal and homozygous familial hypercholesterolemic subjects. (1987) (3)
- Alveolar brush cells in an infant with desquamative interstitial pneumonitis. (1988) (3)
- Intestinal current measurement (ICM) as a new diagnostic test for cystic fibrosis (CF) (2011) (2)
- Hyperlipidaemia and cardiovascular disease. (2007) (2)
- Serum lipase levels as a diagnostic marker in cystic fibrosis patients with normal or borderline sweat tests (2000) (2)
- Effect of lovastatin on lipoprotein fluidity in patients with hypercholesterolaemia. (1992) (2)
- Involvement of second messengers in lipopolysaccharide stimulation of low density lipoprotein uptake by macrophages. (1994) (2)
- The 3849+10 kB C—>T Mutation in a 21-Year-Old Patient with Cystic Fibrosis (1996) (2)
- Sedimentation and adhesion of blood platelets under a centrifugal force (1985) (2)
- Collecting clinical data in primary ciliary dyskinesia- challenges and opportunities. (2016) (2)
- 41* PTC124 activity in CF patients carrying stop mutations: results of a phase 2 study (2007) (2)
- Compound heterozygosity for abetalipoproteinaemia and familial hypobetalipoproteinaemia. (1990) (2)
- P217 Cystic fibrosis with pancreatic insufficiency is associated with a high incidence of subfertility in women (2018) (2)
- [Platelet hypoactivity in hypocholesterolemia]. (1991) (2)
- Platelet adhesion in hyperlipidemic and hypertensive patients. (1985) (2)
- Editorial: Nitro-fatty acids: novel drug candidates for the co-treatment of atherosclerosis and nonalcoholic fatty liver disease. (2020) (2)
- Applied nutritional investigation Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: Studies in vitro and in diabetic patients (2010) (2)
- Massive Pneumomediastinum and Subcutaneous Emphysema Secondary to Foreign Body Aspiration. (2021) (2)
- Metformin inhibits macrophage cholesterol biosynthesis rate: Possible role for metformin-induced oxidative stress (2014) (2)
- Genetic variants associated with cardiovascular diseases and related risk factors highlight novel potential therapeutic approaches. (2021) (2)
- 1WS04-4 Flavonoids-rich nutrients with potent antioxidant activity prevent atherosclerosis development (2003) (2)
- beta-Galactosidase-modified low density lipoprotein demonstrates increased susceptibility to lipid peroxidation and enhanced uptake by macrophages. (1994) (1)
- [Intralipid infusion in familial hypercholesterolemia]. (1989) (1)
- Extracellular matrix contributes to macrophage foam cell formation and atherosclerosis (2001) (1)
- Oxidized low-density lipoprotein reduces plasma coagulation in vitro. (1991) (1)
- The isoflavan glabridin inhibits LDL oxidation: structural and mechanistic aspects. (1999) (1)
- Increased macrophage atherogenicity following exposure to ultrafine particles (2013) (1)
- Serum Immunoglobulin‐Lipid Complexes in Plasma Cell Dyscrasia (1985) (1)
- [Olive oil dietary supplementation decreases susceptibility of LDL to oxidation and its uptake by macrophages]. (1993) (1)
- [Dietary soya lecithin decreases plasma triglyceride and inhibits platelet aggregation]. (1984) (1)
- Enhanced degradation of high density lipoprotein by peritoneal macrophages from nude mice is attenuated by interleukin-1. (1993) (1)
- Effects of prolonged fasting on lipid and lipoprotein concentrations in markedly obese patients (1986) (1)
- 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency (1989) (1)
- Clinical characteristics predicting deterioration in previously healthy infants with RSV infection. † 528 (1997) (1)
- 3.P.30 Is it possible to reduce LDL oxidizability in normolipidemic subjects by antioxidant and fat modification of eggs (1997) (1)
- [The influence of fat diet on plasma lipids and lipoproteins and platelet function]. (1986) (1)
- [Platelet function in hyperlipidemic patients]. (1981) (1)
- [Cholesterol oxidation, macrophage foam cells and atherosclerosis: importance of antioxidants and paraoxonase]. (1999) (1)
- DIETARY LICORICE-ROOT ANTIOXIDANTS REDUCE HEART DISEASES (2004) (1)
- Enteropathy – a new finding in cystic fibrosis (2008) (1)
- From rigid to flexible bronchoscopy: a tertiary center experience in removal of inhaled foreign bodies in children (2021) (1)
- Plasma lipids and lipoproteins in normo- and in hyperlipidemic rabbits fed plant protein diets (1984) (1)
- [Plasma lipid peroxidation: inhibited by drinking red wine but stimulated by white wine]. (1994) (1)
- Chylomicron-like particles in severe hypertriglyceridemia (1985) (1)
- Lipoprotein (LDL and HDL) Oxidation in Diabetes Mellitus (2014) (1)
- Sequential morphological and biochemical events . Phagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell (2005) (0)
- 208 THE ANTIATHEROGENIC PROPERTIES OF HDL AFTER BARIATRIC SURGERY (2011) (0)
- 223 Infertility among women with cystic fibrosis: prevalence and risk factors (2016) (0)
- Prostate Cancer Prostate-Specific Antigen following Surgery or Radiation for Phase II Study of Pomegranate Juice for Men with Rising Updated (2006) (0)
- ePS06.7 Factors associated with failure to eradicate first or newly acquired Pseudomonas aeruginosa in patients with CF (2015) (0)
- 147 Causes of failure to eradicate Pseudomonas aeruginosa in patients with CF (2014) (0)
- Tu-P7:93 Involvement of pro- or anti-atherosclerotic proteins in early stages of atherogenesis (2006) (0)
- 958 Enteropathy- a New Finding in Cystic Fibrosis (2008) (0)
- [Platelet function during alimentary lipemia in type IV hyperlipidemia]. (1986) (0)
- Atherosclerosis: The Apolipoprotein E-Deficient Mouse Model Revisited (2002) (0)
- A 9-Year-Old Boy With Recurrent Chest Pain and Nonresolving Pneumonia. (2020) (0)
- A Randomized Placebo Controlled Sequential Trial of Vitamin A in Bronchiolitis. 84 (1997) (0)
- MS168 UROKINASE PLASMINOGEN ACTIVATOR (UPA) PROVOKES MACROPHAGE ATHEROGENICITY AND APOPTOSIS (2010) (0)
- WO4-OR-5 UROKINASE PLASMINOGEN ACTIVATOR (UPA) UPREGULATES MACROPHAGE PARAOXONASE 2 (PON2) EXPRESSION IN A REDOX-DEPENDENT PATHWAY (2007) (0)
- 1052: Antioxidant Intake Increases Intraca Vernosal Blood Flow and Prevents Erectile Tissue Fibrosis (2005) (0)
- 83 RELIABLE NON-INVASIVE MONITORING OF THEOPHYLLTNE THERAPY IN INFANTS AND CHILDREN: MEASUREMENT OF SALIVA THEOPHYLLINE CONCENTRATIONS (1986) (0)
- Th-W46:5 Oxidized LDL induces monocyte-to-macrophage differentiation through activation of the M-CSF receptor (2006) (0)
- WS15.5 Electrophysiological tests in CF diagnosis: nasal potential difference is more predictive than sweat test – single center study (2017) (0)
- Oxidized LDL binds to macrophage-secreted extracellular matrix and is taken up by macrophages: An alternative approach to studies on lipoprotein cellular uptake (2000) (0)
- Oxidation of platelets enhances platelet aggregation (1994) (0)
- [The mechanisms of action of aspirin in thromboembolic disease]. (1979) (0)
- High Glucose Up-regulates C-Reactive Protein Production (2010) (0)
- [Combined familial hypercholesterolemia and type III hyperlipoproteinemia]. (1984) (0)
- Postprandial markers of inflammation and oxidation following different fatty meals (Mediterranean vs. Western) (2003) (0)
- [Familial hypercholesterolemia]. (1982) (0)
- [Secondary hyperlipidemia in liver diseases]. (1983) (0)
- Interference in a Glucose Dehydrogenase-Based Glucose Meter (2010) (0)
- Compoundheterozygosity forabetalipoprotein aemia andfamilial hypobetalipoprot einaemia ShlomoKeidar, AmosEtzioni, JGeraldBrook, RuthGershoni-Baruch, MichaelAviram (1990) (0)
- Contents, Vol. 15, 1985 (1985) (0)
- Pneumopericardium in a neonate with respiratory syncytial virus and Mycoplasma pneumoniae bronchiolitis: An unusual complication with unusual timing (2020) (0)
- Sex Differences in Obstructive Coronary Artery Disease in Patients 65 Years of Age or Older with Angina Pectoris (2005) (0)
- Colorimetric Polymer Assay for the Diagnosis of Plasma Lipids Atherogenic Quality in Hypercholesterolemic Patients (2015) (0)
- 1.P.184 Lycopene and β-carotene inhibit cholesterol synthesis and augment LDL receptor activity in macrophages (1997) (0)
- cell surface endocytic itinerary, resulting in retention of low-density lipoprotein on the Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the (2013) (0)
- Niemann–Pick C type 1 with severe pulmonary manifestations (2013) (0)
- Th-P15:163 Increased macrophage oxidative stress via-NADPH-oxidase activation and impaired cholesterol fluxes in diabetic mice: Role of cellular glucose uptake (2006) (0)
- 119: 3-HYDROXY 3-METHYL-GLUTARYLCO-ALYASE DEFICIENCY (1988) (0)
- Role of angiotensin II in lipoprotein oxidation and cholesterol metabolism in the vascular wall (2000) (0)
- [Increased propensity to oxidation of LDL of hypertensives]. (1992) (0)
- 1.W06.4 Macrophages and LDL oxidation (1997) (0)
- Synergistic compositions of lycopene and vitamin E, which prevent LDL oxidation of the (1998) (0)
- Resveratrol fails to provide prophylactic protection in a rat model of organophosphate poisoning (2016) (0)
- M.653 Paraoxonase 2 expression is up-regulated by NADPH oxidase during monocyte differentiation into macrophages (2004) (0)
- 256 Improved outcome in cystic fibrosis – results of the Israeli CF Patient Registry 2005–2013 (2016) (0)
- CF Patientsʼ Response To Exercise At Low Altitude (the Dead Sea): 2268 Board#57 9:00AM – 10:30AM (2005) (0)
- Atherogenicity of Monosaccharides, Disaccharides and Artificial Sweeteners in the Lipid-Laden Macrophage Model System: Cell Culture and Mice Studies (2017) (0)
- The role of HDL apoproteins in selective transport of excess intracellular cholesterol from cells (1989) (0)
- Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice (2016) (0)
- Serum from patients with chest pain and significant atherosclerosis resulted in macrophage cholesterol accumulation (2020) (0)
- [Importance of early diagnosis of hyperlipidemias in the prevention of atherosclerosis]. (1995) (0)
- Pomegranate: A Most Potent Protector Against Cardiovascular Diseases (2004) (0)
- 293 UROKINASE PLASMINOGEN ACTIVATOR (UPA) AND ATHEROSCLEROSIS (2011) (0)
- 4.P.157 Dietary polyphenols inhibit LDL oxidation and attenuate atherosclerosis in apolipoprotein E deficient mice (1997) (0)
- Abstract 1201: Haptoglobin Genotype is a Key Regulator of Reverse Cholesterol Transport in Diabetes In Vitro and In Vivo (2006) (0)
- Correction to: From rigid to flexible bronchoscopy: a tertiary center experience in removal of inhaled foreign bodies in children (2021) (0)
- Tu-P8:310 Urokinase plasminogen activator (UPA) stimulates macrophage cholesterol biosynthesis via increment of cellular oxidative state (2006) (0)
- Therapy Is the Result of Their Increased Cellular Cholesterol Content : Effect of Atorvastatin Decreased Macrophage Paraoxonase 2 Expression in Patients With Hypercholesterolemia (2003) (0)
- INCREASEDPLATELETADHESIONAND AGGREGATION IN HYPERTENSIVEPATIENTS:EFFECTOFATENOLOL (1983) (0)
- Cholesterol induced lipid accumulation in cardiomyocytes. (1993) (0)
- Increased macrophage cholesterol accumulation by serum from patients with chest pain and significant atherosclerosis (2020) (0)
- CLINICAL AND GENETIC RISK FACTORS FOR THE DEVELOPMENT OF LIVER DISEASE IN CYSTIC FIBROSIS. (1997) (0)
- THEOPHYLLINE THERAPY MONITORING USING 24 H SALIVA THEOPHYLLINE CONCENTRATION PROFILES IN AMBULATORY ASTHMATICS (1987) (0)
- Subject Index, Vol. 13, 1983 (1983) (0)
- Editorial (2020) (0)
- Plasma and lipoprotein oxidation in apo E-deficient mice with severe hypercholesterolemia and atherosclerosis (1994) (0)
- Basic research Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice (2000) (0)
- PO11-300 A DESIGN OF EXOGENOUS MARKERS OF OXIDATIVE STRESS: A NEW STRATEGY FOR THE DEVELOPMENT OF THE IDEAL MARKER (2007) (0)
- [Inhibition of cellular uptake of low-density lipoprotein by mouse peritoneal macrophages that were pre-exposed in vivo to platelet secretory products]. (1993) (0)
- Selective distribution of oxysterols in human plasma, plasma lipoproteins and atherosclerotic lesions (2000) (0)
- Atherosclerosis Reviews, volume 24: High Density Lipoproteins - Patho-physiology and Clinical Relevance. (1994) (0)
- Platelet adhesion determination in whole blood using a simple stagnation flow method (2006) (0)
- [Addition of pomegranate juice to statin inhibits cholesterol accumulation in macrophages: protective role for the phytosterol beta-sitosterol and for the polyphenolic antioxidant punicalagin]. (2013) (0)
- PO20-605 POMEGRANATE JUICE CONSUMPTION PROTECTS AGAINST CVD: MECHANISM OF ACTION (2007) (0)
- W06.172 Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter: A possible role for lysophosphatidylcholine (2004) (0)
- W01.20 Cell capacity to oxidize LDL increases during monocyte-to-macrophage differentiation (2004) (0)
- LDL content of β-carotene protects against macrophage mediation of LDL oxidation (1995) (0)
- Abstracts from Rambam Research Day, December 11, 2014 (2015) (0)
- [Treatment of hyperlipidemia with bezafibrate]. (1986) (0)
- Cystic fibrosis : new aspects of diagnosis , inflammation and detecting exacerbation 361 Intestinal current measurement ( ICM ) as a new diagnostic test for cystic fibrosis ( CF ) (2011) (0)
- ANTIATHEROGENICITY AND ANTIOXIDATIVE PROPERTIES OF POLYPHENOLIC FLAVONOIDS AGAINST LDL OXIDATION (1999) (0)
- From rigid to flexible bronchoscopy: A tertiary center experience in extraction of inhaled foreign bodies in children (2020) (0)
- 3 Macrophages and LDL oxidation (1997) (0)
- [Platelet-modified LDL: uptake and metabolism in macrophages]. (1989) (0)
- [The effect of plasma lipoproteins on blood platelets and its relation to atherosclerosis]. (1984) (0)
- Reduced plasma high-density lipoprotein (HDL) and increased platelet activity in arterial vs. venous blood (1986) (0)
- [The atherogenic aspect of the lipoprotein composition in hemodialysis patients]. (1986) (0)
- Neonatal presentation of double aortic arch: Case series and literature review (2021) (0)
- Subject Index, Vol. 15, 1985 (1985) (0)
- Correspondence (0)
- LDL modifications by phospholipases and foam cell formation (1994) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Michael Y. Aviram?
Michael Y. Aviram is affiliated with the following schools:
